Lumretuzumab
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | ERBB3 |
Clinical data | |
Other names | RG7116 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6512H10064N1736O2052S44 |
Molar mass | 146916.88 g·mol−1 |
Lumretuzumab (INN; development code RG7116) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]
This drug was developed by Genentech/Roche.
References
Categories:
- Articles with short description
- Short description is different from Wikidata
- Drugs not assigned an ATC code
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a monoclonal antibody
- Monoclonal antibodies
- All stub articles
- Monoclonal antibody stubs